USANA Health Sciences Inc. - Q1 2007 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2007. USANA Health Sciences, Inc. develops, manufactures, and distributes nutritional and personal care products primarily through a network marketing system of independent "Associates" and direct sales to "Preferred Customers." The company operates two reportable segments: Direct Selling and Contract Manufacturing. As of March 31, 2007, the company had approximately 160,000 active Associates and 80,000 active Preferred Customers worldwide.
Key Financial Metrics
| Metric (in thousands) | Q1 2007 | Q1 2006 |
|---|---|---|
| Net Sales | $102,567 | $88,229 |
| Gross Profit | $79,980 | $66,891 |
| Gross Margin | 78.0% | 75.8% |
| Net Earnings | $11,686 | $9,560 |
| Diluted EPS | $0.63 | $0.50 |
| Operating Cash Flow | $16,238 | $15,377 |
| Cash and Equivalents (End of Period) | $32,496 | $25,505 |
| Debt | $0 (Line of Credit Undrawn) | $0 |
Note: Subsequent to the quarter end, the company drew $20.6 million on its line of credit to fund share repurchases.
Material Changes vs. Prior Period
- Revenue Growth: Consolidated net sales increased 16.3% year-over-year. The Direct Selling segment grew 17.9%, driven by a 17.6% increase in active Associates and the launch of operations in Malaysia (contributing $3.1 million). The Contract Manufacturing segment declined 32.4% as the company focused on internal Sensé production rather than third-party contracts.
- Profitability: Net earnings rose 22.2% to $11.7 million. Gross margin improved to 78.0% due to lower raw material costs, production efficiencies, and a shift in sales mix toward the higher-margin Direct Selling segment.
- Expenses: Associate incentives decreased as a percentage of sales (39.3% vs. 39.9%) due to fewer promotions in North America. Selling, General, and Administrative (SG&A) expenses increased 22.1% in absolute terms, driven by equity-based compensation, market expansion costs, and legal/PR expenses related to negative media coverage.
- Capital Expenditures: Investing cash outflows increased significantly to $8.8 million, primarily for the purchase of a facility in Australia ($6.0 million) and expansion of the corporate headquarters.
Guidance, Outlook, and Risks
- Guidance Adjustment: Management has lowered full-year 2007 sales growth guidance to 13-15% (previously higher) and adjusted earnings per share growth expectations to 16-18%. This downward revision is attributed to uncertainties surrounding negative media coverage and the costs associated with addressing misinformation.
- Q2 Outlook: Second-quarter net sales are projected between $103 million and $105 million. Diluted EPS is expected to be between $0.63 and $0.65.
- Legal Proceedings: Three class-action lawsuits were filed alleging violations of federal securities laws regarding statements about the multi-level marketing industry. Additionally, the company filed a defamation lawsuit against Barry Minkow and the Fraud Discovery Institute. The SEC has initiated an informal inquiry regarding the company.
- Share Repurchases: The Board approved an additional $40 million for share repurchases. Between April 1 and April 30, 2007, the company repurchased 1,075 shares for $46.6 million.
Investor Verification Checklist
- Legal Exposure: Monitor the status of the three class-action lawsuits and the SEC informal inquiry, as these could result in significant costs or reputational damage.
- Associate Retention: Verify if the negative media coverage impacts the growth rate of active Associates, which is the primary driver of revenue.
- Capital Allocation: Track the utilization of the $40 million share repurchase authorization and the impact of the $20.6 million line of credit draw on liquidity.
- International Expansion: Assess the performance of the new Malaysia market and the integration of the new Australia facility.
- Margin Sustainability: Confirm if the improved gross margins are sustainable given potential raw material price fluctuations and the mix of sales between segments.